Loading...
XHKG
0660
, Last price  
HKD
Name

Wai Chun Bio Technology Ltd

Chart & performance

D1W1MN
XHKG:0660 chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
1.47%
Rev. 5Y
-0.38%
Div Yld LY
—
Div Yld TTM
—
Revenues
568m
+50.67%
297,638,000132,418,00068,080,00082,480,00013,137,000284,128,000362,310,000386,678,000373,582,000394,116,000376,808,000464,807,000512,133,000480,852,000579,231,000567,553,000671,460,690773,654,000377,168,000568,262,000
Net income
-7m
L-52.81%
-52,386,000-53,913,000-94,733,000-66,110,000-22,743,00020,305,000-3,729,000-34,135,000-22,170,000-17,704,000-19,596,000-39,169,000-17,399,000-53,617,0008,988,000995,000-14,363,405-15,433,000-14,623,000-6,901,000
CFO
-1m
L
-18,505,0008,359,000-23,652,000-12,712,000-52,510,000-26,610,000-34,667,000-44,655,000-112,953,000132,411,000-15,837,000-6,849,000-14,734,0008,928,000-6,889,00014,272,000-413,000390,00045,413,000-1,016,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Wai Chun Bio-Technology Limited operates as an investment holding company, primarily focusing on the production and distribution of modified starches and various other biochemical products across the People's Republic of China. Additionally, the firm engages in the trading of electronic components, electrical appliances, and a diverse range of footwear, encompassing athletic, sport-style, work, safety, golf, and other functional shoes. The company was formerly named Wai Chun Mining Industry Group Company Limited before officially adopting its current identity in September 2019. Its principal corporate offices are situated in Admiralty, Hong Kong.

Key people

Executive Chairman of the Board, Chief Executive Officer · since 2013
Company Secretary · since 2018
Company Secretary · since 2019
Independent Non-Executive Director · since 2007
Pak Man Hau
Independent Non-Executive Director · since 2012
Jinyuan Li
Non-Executive Independent Director · since 2020
IPO date
Feb 05, 1993
Employees
156
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑122025‑062023‑062022‑062020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT